#United States #New York #Securities Law #Faruqi & Faruqi #Baxter International

Investor Alert: Time to Act for Baxter International Investors

As the investor deadline approaches, those who have incurred losses exceeding $100,000 in Baxter International Inc. are encouraged to take action. Faruqi & Faruqi, LLP, a prominent national securities law firm, is currently exploring potential claims against Baxter International as part of an impending federal securities class action lawsuit.

Identify Your Rights

If you're an investor affected by Baxter’s alleged misleading statements or practices between February 23, 2022, and July 30, 2025, now is the time to evaluate your legal rights. James (Josh) Wilson, a partner at Faruqi & Faruqi, is available to discuss your case and the implications of your investment losses. You can reach him directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Background on Baxter International

Baxter International, publicly traded under the NYSE symbol BAX, has been under scrutiny for its handling of the Novum LVP (Large Volume Pump). Allegations have emerged regarding systemic defects with this product, which has affected patient safety through issues like underinfusion and overinfusion, putting patients at risk of serious injury or even death.

The firm states that Baxter was notified of numerous malfunctions and injuries but failed to take adequate corrective measures. Instead, internal alerts were issued that did not effectively address the design flaws, and complaints continued to escalate.

Recent Developments

The turning point for the case occurred on July 31, 2025, when Baxter announced a voluntary and temporary halt to shipments and planned installations of the Novum LVP. This announcement triggered a significant drop in Baxter's stock price, plummeting by 22.4% to close at $21.76. This decline highlighted the potential impact of the company's failure to disclose critical safety issues regarding their product.

Join the Class Action

The upcoming deadline of December 15, 2025, marks a crucial date for anyone looking to serve as lead plaintiff in this class action suit against Baxter International. Being part of the lead plaintiff group allows individuals to direct the litigation process, representing others affected by Baxter's alleged negligence.

However, participating in the class action is not mandatory. Investors can still choose to remain as absent class members, preserving whatever rights they have to potential recovery without affecting the outcome of the lawsuit.

Get Involved

Faruqi & Faruqi is not only seeking investors directly impacted by the recent developments but is also interested in gathering information from whistleblowers or former Baxter employees who could shed light on the company’s practices. This effort aims to support ongoing investigations that may unveil deeper issues and assist affected investors.

Conclusion

In summary, if you have experienced significant losses related to your investment in Baxter International, you are not alone. Reach out to Faruqi & Faruqi to explore your options and protect your rights as they prepare for what could be a significant legal battle against Baxter. Visit their website at www.faruqilaw.com/BAX to learn more and stay updated on developments in the litigation process.